Maprotiline

This classification denotes an antidepressant agent with the molecular formula C20H23N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2U1W68TROF, chemically known as 9,10-ethanoanthracene-9(10h)-propylamine, n-methyl- but generally known as maprotiline, which bears US NIH Compound Identifier 4011. European Medicines Agency schedules Maprotiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08647MIG. The term MAPROTILINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules maprotiline in its Anatomical Therapeutic Chemical (ATC) Classification. MAPROTILINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule maprotiline under HS 29214980 and SITC 51454. As of Q4 2014, MAPROTILINE remains the US FDA Preferred Term for this commodity. Maprotiline bears US NLM identifiers UMLS ID C0024778 and NCI Concept Code C61824. SMILES: N(CCCC12CCC(c3c1cccc3)c1c2cccc1)C.